EGEGazette
BusinessReported
Novo Nordisk Rebrands to 'Novo,' CEO Says Obesity Strategy Needs Rethink
In an interview with CNBC, new chief executive Mike Doustdar said the Danish drugmaker's rebranding marks a new chapter as it faces intensifying competition from Eli Lilly.
· 1 min read